JFJoão Gonçalves Filho

João Gonçalves Filho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


João Gonçalves Filho has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gastric adenocarcinoma and periodontal disease: A systematic review and meta-analysis

    by Francisco José Nunes Aguiar, Fabrício dos Santos Menezes, Marcela de Araújo Fagundes, Gisele Aparecida Fernandes, Fabio de Abreu Alves, João Goncalves Filho, Maria Paula Curado


  • Open Access

    Analysis of muscle mass by computed tomography in patients with head and neck cancer: a prospective study

    by Thais Manfrinato Miola, Almir Galvão Vieira Bitencourt, Juliana de Oliveira Souza, Luiz Paulo Kowalski, João Gonçalves Filho

    Objective: To evaluate the preoperative muscle mass of patients with head and neck cancer (HNC) with computed tomography (CT), comparing the results obtained through analysis of cross-sectional areas at the level of the third lumbar vertebra (L3) with those obtained through analysis of cross-sectional areas at the levels of the third cervical and fourth thoracic vertebrae (C3 and T4, respectively). Materials and Methods: A total of 63 patients with HNC were evaluated preoperatively. Using CT, we assessed muscle mass at L3, as well as at C3 and T4. Results: Most (73.0%) of the patients had low muscle mass at L3, whereas 50.8% had a normal body mass index. The cross-sectional area at L3 correlated strongly with those at C3 and T4 (r = 0.831 and r = 0.763, respectively; p < 0.001 for both). In addition, the muscle mass index at L3 correlated strongly with those at C3 and T4 (r = 0.781 and r = 0.715, respectively; p < 0.001 for both). Conclusion: Low muscle mass appears to be highly prevalent in patients with HNC. Measurements at C3 and T4 could represent alternative means of assessing muscle mass in such patients.


  • Open Access

    Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma

    by Aline de Oliveira Ribeiro Viana, João Gonçalves Filho, Ana Lúcia Noronha Francisco, Clóvis Antônio Lopes Pinto, Luiz Paulo Kowalski

    Most patients with papillary thyroid carcinoma have good prognosis; however, recurrence rates and the need of salvage treatment remain a significant problem for 5-40% of patients. Although several risk classifications based on clinicopathological prognostic factors are used, it is not possible to predict which patients will have a higher risk of recurrence. The objective of the study is to analyse the impact of cytokeratin-19 and Ki-67 immunoexpression as predictive markers of the risk of recurrence in papillary thyroid carcinoma. This is a retrospective case-control study, including 42 patients with papillary thyroid carcinoma and 42 controls. The groups were matched by gender, age and pathological staging T and N. Slides were made by the microarray tissue system. Multivariate logistic regression was applied to identify an independent risk factor for recurrence. Of the 42 selected cases, 30 patients (71.4%) were female and 12 (28.6%) were male, ranging in age from 10 to 80 years (median of 39 years). Most patients (64.3%) had tumors at initial T staging (T1-T2). Half of the sample was classified as low risk according to the American Thyroid Association (ATA) risk stratification. Follow-up time ranged from 46 to 196 months, with time to recurrence from 2 to 106 months (median, 30 months). CK-19 and Ki-67 immunoexpression had a statistically significant association with the risk of recurrence (p = 0.029 and p = 0.007, respectively). In multivariate logistic regression analysis, immunoexpression for these markers was an independent risk factor for locoregional recurrence (OR-9,64; CI-1.14-81.01 and OR-3,21; CI-1.32-7.94, respectively). The immunohistochemical analysis of the Ki-67 and CK-19 markers is useful to predict tumour recurrence in patients with papillary thyroid carcinoma.


  • Endoscopic Transpterygoid Nasopharyngectomy for Nasopharyngeal Malignant Tumors

    by Ronaldo N. Toledo, Paula A. Silveira, João Gonçalves Filho, José G. Vartanian, Mauro K. Ikeda, Luiz P. Kowalski

    Background: The current treatment for most nasopharyngeal neoplasms is radiotherapy or radiochemotherapy. In some cases, such as adenoid cystic carcinomas and recurrent nasopharyngeal squamous carcinoma, primary or salvage surgery may play an important role. However, these surgeries are sometimes difficult to perform and the results vary according to tumor size, complexity of resection and status of surgical margins. Objectives: The aim of this study was to describe the results of primary endoscopic transpterygoid nasopharyngectomy approach for adenoid cystic carcinomas or as a salvage procedure for recurrent nasopharyngeal squamous carcinoma. Patients and Methods: From June 2007 to April 2013, twelve patients with nasopharyngeal malignant tumors were treated with surgical endoscopic approach at a single institution. This surgery was performed in patients with tumors not involving the internal carotid artery, soft palate, and without intracranial or clivus extension. Results: Twelve patients underwent 13 surgeries. Histopathology types were recurrent carcinoma of the nasopharynx (7 patients, 8 surgeries) and adenoid cystic carcinoma (5 surgeries). Complete resection with negative microscopic margins was achieved in 11 of the 13 surgeries. In 2 patients with adenoid cystic carcinoma, the resection margins were positive. Both underwent postoperative radiotherapy. One remains disease free for 21 months and the second patient has symptomatic tumor after 19 months of follow-up. Among the 11 cases that had negative margins, there were four relapses: one at the contralateral nasopharynx, other in the soft palate and two patients in cavernous sinus. The patient with contralateral nasopharyngeal relapse was submitted to a second endoscopic salvage surgery and remains disease free for 65 months. The patient with palate recurrence underwent wide resection via midfacial degloving and remains disease free for 24 months. The 2 patients with recurrence in cavernous sinus are alive with symptomatic disease. There were no major intraoperative complications or mortality. There was one postoperative death due to internal carotid artery rupture on the 25th postoperative day. One patient had pharyngeal stenosis. Adjuvant radiotherapy was performed in 4 of 5 cases of adenoid cystic carcinoma. After a period of follow up from 5 to 75 months, there were one postoperative death, 2 patients with local persistent disease and 2 who underwent a second salvage surgery. Nine patients were without evidence of disease at last follow up. Conclusion: Endoscopic transpterygoid nasopharyngectomy is feasible and may be a good option for the surgical treatment of selected patients with primary or recurrent nasopharynx malignant neoplasms without clivus, dura mater or intracranial invasion and not involving the internal carotid artery and soft palate.